External validation of the GREAT score to predict relapse risk in Graves' disease: results from a multicenter, retrospective study with 741 patients.
Struja T, Kaeslin M, Boesiger F, Jutzi R, Imahorn N, Kutz A, Bernasconi L, Mundwiler E, Mueller B, Christ-Crain M, Meienberg F, Ebrahimi F, Henzen C, Fischli S, Kraenzlin M, Meier C, Schuetz P.
Struja T, et al.
Eur J Endocrinol. 2017 Apr;176(4):413-419. doi: 10.1530/EJE-16-0986. Epub 2017 Jan 18.
Eur J Endocrinol. 2017.
PMID: 28100628